FNY Managed Accounts’s Verastem VSTM Stock Holding History

FNY Managed Accounts’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-42	Closed	-$1K	–	855
2017 Q4	$1K	Buy	+42	New	+$1.9K	﹤0.01%	614

Other funds holding VSTM

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

FNY Managed Accounts's VSTM Position: Q1 2018 in Review

FNY Managed Accounts sold out of Verastem (VSTM) in Q1 2018, closing a stake of 42 shares — an estimated $1K sold.

FNY Managed Accounts first reported a position in VSTM in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 78 funds tracked by Wall St. Rank hold VSTM as of Q1 2018.

FNY Managed Accounts reported no remaining Verastem position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 42 Verastem shares in Q1 2018, an estimated $1K.
FNY Managed Accounts first reported a position in Verastem in Q4 2017 and held it in 1 quarter.
FNY Managed Accounts's Verastem position peaked at $1K in Q4 2017.
78 funds tracked by Wall St. Rank held Verastem as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.